Protalix BioTherapeutics Inc. (PLX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Protalix BioTherapeutics ...

    AMEX: PLX · Real-Time Price · USD
    1.65
    0.10 (6.45%)
    At close: Sep 02, 2025, 3:59 PM
    1.64
    -0.30%
    After-hours: Sep 02, 2025, 07:50 PM EDT

    Protalix BioTherapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 46.51 14.46 -4.45 -1.33
    PEG Ratio
    		 -0.7 -0.1 0.09 -0.01
    PS Ratio
    		 2.55 1.83 1.39 0.96
    PB Ratio
    		 3.16 3.58 -6.24 -6.08
    P/FCF Ratio
    		 18.45 -48.71 -2.59 -3.13
    P/OCF Ratio
    		 15.72 -91.18 -2.66 -3.57
    OCF/S Ratio
    		 0.16 -0.02 -0.52 -0.27
    Debt / Equity Ratio
    		 0.13 0.78 -3.15 -5.55
    Quick Ratio
    		 1.52 1.12 0.87 1.32
    Current Ratio
    		 2.34 1.54 1.38 1.86
    Asset Turnover
    		 0.73 0.78 0.85 0.52
    Interest Coverage
    		 3.69 3.29 -5.15 -2.72
    Return on Equity
    		 0.07 0.25 1.40 4.57
    Return on Assets
    		 0.04 0.10 -0.27 -0.37
    Return on Invested Capital
    		 0.05 0.16 -0.53 -0.48
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.54 0.65 0.59 0.57
    Net Profit Margin
    		 0.05 0.13 -0.31 -0.72
    Pretax Profit Margin
    		 0.08 0.13 -0.3 -0.72
    Operating Profit Margin
    		 0.07 0.16 -0.27 -0.53
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 0.12 0.20 -0.23 -0.49

    Add to Watchlist